Susan Schenk - Publications

Affiliations: 
Psychology Texas A & M University, College Station, TX, United States 
Area:
addiction

93 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Aronsen D, Schenk S. MDMA self-administration fails to alter the behavioral response to 5-HT1A and 5-HT1B agonists. Psychopharmacology. PMID 26856854 DOI: 10.1007/s00213-016-4226-9  0.96
2016 Aronsen D, Bukholt N, Schenk S. Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms. Psychopharmacology. PMID 26856853 DOI: 10.1007/s00213-016-4225-x  0.96
2015 Schenk S, Bradbury S. Persistent sensitisation to the locomotor activating effects of MDMA following MDMA self-administration in rats. Pharmacology, Biochemistry, and Behavior. 132: 103-107. PMID 25757377 DOI: 10.1016/j.pbb.2015.03.001  0.96
2015 Lee K, Goodman L, Fourie C, Schenk S, Leitch B, Montgomery JM. AMPA Receptors as Therapeutic Targets for Neurological Disorders Advances in Protein Chemistry and Structural Biology. DOI: 10.1016/bs.apcsb.2015.10.004  0.96
2014 Aronsen D, Webster J, Schenk S. RU 24969-produced adipsia and hyperlocomotion: differential role of 5HT 1A and 5HT 1B receptor mechanisms. Pharmacology, Biochemistry, and Behavior. 124: 1-4. PMID 24844705 DOI: 10.1016/j.pbb.2014.05.008  0.96
2014 Harper DN, Langen AL, Schenk S. A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA. Pharmacology, Biochemistry, and Behavior. 116: 9-15. PMID 24252442 DOI: 10.1016/j.pbb.2013.11.011  0.96
2014 Bradbury S, Bird J, Colussi-Mas J, Mueller M, Ricaurte G, Schenk S. Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release. Addiction Biology. 19: 874-84. PMID 23763615 DOI: 10.1111/adb.12069  0.96
2014 Oakly AC, Brox BW, Schenk S, Ellenbroek BA. A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats. Molecular Psychiatry. 19: 534-5. PMID 23711978 DOI: 10.1038/mp.2013.75  0.96
2013 Schenk S, Abraham B, Aronsen D, Colussi-Mas J, Do J. Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT. Psychopharmacology. 227: 355-61. PMID 23354536 DOI: 10.1007/s00213-013-2980-5  0.96
2013 Bird J, Schenk S. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration. Addiction Biology. 18: 654-64. PMID 22784256 DOI: 10.1111/j.1369-1600.2012.00477.x  0.96
2013 Do J, Schenk S. Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain. Addiction Biology. 18: 441-7. PMID 21955305 DOI: 10.1111/j.1369-1600.2011.00370.x  0.96
2012 Bradbury S, Gittings D, Schenk S. Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and Dâ‚‚-like agonists. Psychopharmacology. 223: 389-99. PMID 22562523 DOI: 10.1007/s00213-012-2726-9  0.96
2012 Morani AS, Schenk S, Prisinzano TE, Kivell BM. A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats. Behavioural Pharmacology. 23: 162-70. PMID 22293826 DOI: 10.1097/FBP.0b013e3283512c1e  0.96
2011 Ali SF, Onaivi ES, Dodd PR, Cadet JL, Schenk S, Kuhar MJ, Koob GF. Understanding the Global Problem of Drug Addiction is a Challenge for IDARS Scientists. Current Neuropharmacology. 9: 2-7. PMID 21886551 DOI: 10.2174/157015911795017245  0.96
2011 Carati C, Schenk S. Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats. Pharmacology, Biochemistry, and Behavior. 98: 449-54. PMID 21334368 DOI: 10.1016/j.pbb.2011.02.010  0.96
2011 Schenk S, Gittings D, Colussi-Mas J. Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. British Journal of Pharmacology. 162: 1770-80. PMID 21198550 DOI: 10.1111/j.1476-5381.2010.01193.x  0.96
2011 Schenk S. MDMA ("ecstasy") abuse as an example of dopamine neuroplasticity. Neuroscience and Biobehavioral Reviews. 35: 1203-18. PMID 21184779 DOI: 10.1016/j.neubiorev.2010.12.010  0.96
2011 Schenk S, Harper DN, Do J. Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals. Journal of Psychopharmacology (Oxford, England). 25: 1043-52. PMID 21148025 DOI: 10.1177/0269881110389213  0.96
2010 Jones K, Brennan KA, Colussi-Mas J, Schenk S. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release. Addiction Biology. 15: 289-98. PMID 20477756 DOI: 10.1111/j.1369-1600.2010.00217.x  0.96
2010 Colussi-Mas J, Wise RJ, Howard A, Schenk S. Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1315-27. PMID 20334725 DOI: 10.1017/S1461145710000283  0.96
2010 Kivell B, Day D, Bosch P, Schenk S, Miller J. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience. 168: 82-95. PMID 20298763 DOI: 10.1016/j.neuroscience.2010.03.018  0.96
2010 Brennan KA, Colussi-Mas J, Carati C, Lea RA, Fitzmaurice PS, Schenk S. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat. Brain Research. 1317: 137-46. PMID 19962371 DOI: 10.1016/j.brainres.2009.11.069  0.96
2009 Schenk S. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology. 60: 130-6. PMID 19893330 DOI: 10.1159/000253549  0.96
2009 Brennan KA, Carati C, Lea RA, Fitzmaurice PS, Schenk S. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behavioural Pharmacology. 20: 688-94. PMID 19881334 DOI: 10.1097/FBP.0b013e328333a28d  0.96
2009 Morani AS, Kivell B, Prisinzano TE, Schenk S. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Pharmacology, Biochemistry, and Behavior. 94: 244-9. PMID 19747933 DOI: 10.1016/j.pbb.2009.09.002  0.96
2008 Colussi-Mas J, Schenk S. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. The European Journal of Neuroscience. 28: 1895-910. PMID 18973603 DOI: 10.1111/j.1460-9568.2008.06467.x  0.96
2008 Mandt BH, Schenk S, Zahniser NR, Allen RM. Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine. Psychopharmacology. 201: 195-202. PMID 18685831 DOI: 10.1007/s00213-008-1265-x  0.96
2008 Schenk S, Hely L, Gittings D, Lake B, Daniela E. Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats. Drug and Alcohol Dependence. 96: 249-55. PMID 18472230 DOI: 10.1016/j.drugalcdep.2008.03.014  0.96
2007 Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC. MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. The European Journal of Neuroscience. 26: 3229-36. PMID 18005064 DOI: 10.1111/j.1460-9568.2007.05932.x  0.96
2007 Brennan KA, Lake B, Hely LS, Jones K, Gittings D, Colussi-Mas J, Fitzmaurice PS, Lea RA, Schenk S. N-benzylpiperazine has characteristics of a drug of abuse. Behavioural Pharmacology. 18: 785-90. PMID 17989516 DOI: 10.1097/FBP.0b013e3282f18d8f  0.96
2007 Johnstone AC, Lea RA, Brennan KA, Schenk S, Kennedy MA, Fitzmaurice PS. Benzylpiperazine: a drug of abuse? Journal of Psychopharmacology (Oxford, England). 21: 888-94. PMID 17606471 DOI: 10.1177/0269881107077260  0.96
2007 Brennan K, Johnstone A, Fitzmaurice P, Lea R, Schenk S. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA). Drug and Alcohol Dependence. 88: 204-13. PMID 17125936 DOI: 10.1016/j.drugalcdep.2006.10.016  0.96
2006 Carroll FI, Fox BS, Kuhar MJ, Howard JL, Pollard GT, Schenk S. Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. European Journal of Pharmacology. 553: 149-56. PMID 17067572 DOI: 10.1016/j.ejphar.2006.09.024  0.96
2006 Daniela E, Gittings D, Schenk S. Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. Behavioral Neuroscience. 120: 1144-50. PMID 17014264 DOI: 10.1037/0735-7044.120.5.1144  0.96
2006 Lambert NM, McLeod M, Schenk S. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Addiction (Abingdon, England). 101: 713-25. PMID 16669905 DOI: 10.1111/j.1360-0443.2006.01408.x  0.96
2006 Harper DN, Hunt M, Schenk S. Attenuation of the disruptive effects of (+/-)3,4-methylene dioxymethamphetamine (MDMA) on delayed matching-to-sample performance in the rat. Behavioral Neuroscience. 120: 201-5. PMID 16492131 DOI: 10.1037/0735-7044.120.1.201  0.96
2006 Brennan KA, Schenk S. Initial deficit and recovery of function after MDMA preexposure in rats. Psychopharmacology. 184: 239-46. PMID 16362399 DOI: 10.1007/s00213-005-0278-y  0.96
2005 Harper DN, Wisnewski R, Hunt M, Schenk S. (+/-)3,4-methylenedioxymethamphetamine, d-amphetamine, and cocaine impair delayed matching-to-sample performance by an increase in susceptibility to proactive interference. Behavioral Neuroscience. 119: 455-63. PMID 15839791 DOI: 10.1037/0735-7044.119.2.455  0.96
2004 Daniela E, Brennan K, Gittings D, Hely L, Schenk S. Effect of SCH 23390 on (+/-)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats. Pharmacology, Biochemistry, and Behavior. 77: 745-50. PMID 15099919 DOI: 10.1016/j.pbb.2004.01.008  0.96
2003 Schenk S, Gittings D, Johnstone M, Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology. 169: 21-7. PMID 12774185 DOI: 10.1007/s00213-003-1407-0  0.96
2003 Schenk S, Gittings D. Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology. 168: 118-23. PMID 12420155 DOI: 10.1007/s00213-002-1276-y  0.96
2002 Schenk S, Izenwasser S. Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine. Pharmacology, Biochemistry, and Behavior. 72: 651-7. PMID 12175462 DOI: 10.1016/S0091-3057(02)00735-9  0.96
2002 Green TA, Schenk S. Dopaminergic mechanism for caffeine-produced cocaine seeking in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 422-30. PMID 11927167 DOI: 10.1016/S0893-133X(01)00343-8  0.96
2002 Schenk S. Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology. 160: 263-70. PMID 11889495 DOI: 10.1007/s00213-001-0972-3  0.96
2001 Schenk S, Partridge B. Effect of the kappa-opioid receptor agonist, U69593, on reinstatement of extinguished amphetamine self-administration behavior. Pharmacology, Biochemistry, and Behavior. 68: 629-34. PMID 11526958 DOI: 10.1016/S0091-3057(00)00478-0  0.96
2001 Schenk S, Partridge B. Influence of a conditioned light stimulus on cocaine self-administration in rats. Psychopharmacology. 154: 390-6. PMID 11349392 DOI: 10.1007/s002130000608  0.96
2001 Schenk S, Partridge B, Shippenberg TS. Effects of the kappa-opioid receptor agonist, U69593, on the development of sensitization and on the maintenance of cocaine self-administration. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 441-50. PMID 11182539 DOI: 10.1016/S0893-133X(00)00190-1  0.96
2000 Schenk S. Effects of the serotonin 5-HT2 antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats Pharmacology Biochemistry and Behavior. 67: 363-369. PMID 11124402 DOI: 10.1016/S0091-3057(00)00377-4  0.96
2000 Schenk S, Partridge B. Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats Pharmacology Biochemistry and Behavior. 66: 765-770. PMID 10973514 DOI: 10.1016/S0091-3057(00)00273-2  0.96
2000 Schenk S, Partridge B, Shippenberg TS. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology. 151: 85-90. PMID 10958121 DOI: 10.1007/s002130000476  0.96
1999 Schenk S, Partridge B. Cocaine-seeking produced by experimenter-administered drug injections: Dose-effect relationships in rats Psychopharmacology. 147: 285-290. PMID 10639687 DOI: 10.1007/s002130051169  0.96
1999 Partridge B, Schenk S. Context-independent sensitization to the locomotor-activating effects of cocaine Pharmacology Biochemistry and Behavior. 63: 543-548. PMID 10462182 DOI: 10.1016/S0091-3057(99)00013-1  0.96
1999 Schenk S, Partridge B, Shippenberg TS. U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology. 144: 339-46. PMID 10435406 DOI: 10.1007/s002130051016  0.96
1998 Heidbreder CA, Schenk S, Partridge B, Shippenberg TS. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse (New York, N.Y.). 30: 255-62. PMID 9776129 DOI: 10.1002/(SICI)1098-2396(199811)30:3<255::AID-SYN3>3.0.CO;2-A  0.96
1998 Schenk S, Davidson ES. Stimulant preexposure sensitizes rats and humans to the rewarding effects of cocaine. Nida Research Monograph. 169: 56-82. PMID 9686411  0.96
1997 Schenk S, Partridge B. Effects of acute and repeated administration of N-methyl-D-aspartate (NMDA) into the ventral tegmental area: Locomotor activating effects of NMDA and cocaine Brain Research. 769: 225-232. PMID 9374190 DOI: 10.1016/S0006-8993(97)00712-9  0.96
1997 Schenk S, Partridge B. Sensitization and tolerance in psychostimulant self-administration Pharmacology Biochemistry and Behavior. 57: 543-550. PMID 9218279 DOI: 10.1016/S0091-3057(96)00447-9  0.96
1996 Schenk S, Worley CM, McNamara C, Valadez A. Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats. Psychopharmacology. 126: 17-23. PMID 8853212 DOI: 10.1007/BF02246406  0.96
1996 Nation JR, Livermore CL, Bratton GR, Schenk S. Chronic cadmium exposure alters cocaine self-administration in adult male rats Experimental and Clinical Psychopharmacology. 4: 264-270. DOI: 10.1037//1064-1297.4.3.264  0.96
1994 Valadez A, Schenk S. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration Pharmacology, Biochemistry and Behavior. 47: 203-205. PMID 8115423 DOI: 10.1016/0091-3057(94)90132-5  0.96
1994 Peltier RL, Emmett-Oglesby MW, Thomas WH, Schenk S. Failure of ritanserin to block the discriminative or reinforcing stimulus effects of cocaine Pharmacology, Biochemistry and Behavior. 48: 473-478. PMID 8090817 DOI: 10.1016/0091-3057(94)90555-X  0.96
1994 Worley CM, Valadez A, Schenk S. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine Pharmacology, Biochemistry and Behavior. 48: 217-221. PMID 8029293 DOI: 10.1016/0091-3057(94)90519-3  0.96
1994 Horger BA, Valadez A, Wellman PJ, Schenk S. Augmentation of the neurochemical effects of cocaine in the ventral striatum and medial prefrontal cortex following preexposure to amphetamine, but not nicotine: an in vivo microdialysis study. Life Sciences. 55: 1245-51. PMID 7934622 DOI: 10.1016/0024-3205(94)00664-4  0.96
1994 Davidson ES, Schenk S. Variability in subjective responses to marijuana: initial experiences of college students. Addictive Behaviors. 19: 531-8. PMID 7832011 DOI: 10.1016/0306-4603(94)90008-6  0.96
1994 Schenk S, Snow S. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus Brain Research. 659: 17-22. PMID 7820659 DOI: 10.1016/0006-8993(94)90858-3  0.96
1994 Schenk S, Valadez A, Horger BA, Snow S, Wellman PJ. Interactions between caffeine and cocaine in tests of self-administration Behavioural Pharmacology. 5: 153-158.  0.96
1993 McNamara CG, Davidson ES, Schenk S. A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacology, Biochemistry, and Behavior. 45: 729-32. PMID 8332631 DOI: 10.1016/0091-3057(93)90532-X  0.96
1993 Davidson ES, Finch JF, Schenk S. Variability in subjective responses to cocaine: initial experiences of college students. Addictive Behaviors. 18: 445-53. PMID 8213299 DOI: 10.1016/0306-4603(93)90062-E  0.96
1993 Schenk S, Valadez A, McNamara C, House DT, Higley D, Bankson MG, Gibbs S, Horger BA. Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology. 111: 332-8. PMID 7870971 DOI: 10.1007/BF02244949  0.96
1993 Peltier R, Schenk S. Effects of serotonergic manipulations on cocaine self-administration in rats Psychopharmacology. 110: 390-394. PMID 7870907 DOI: 10.1007/BF02244643  0.96
1993 Schenk S, Valadez A, Worley CM, McNamara C. Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (dizocilpine) Behavioural Pharmacology. 4: 652-659.  0.96
1992 Horger BA, Giles MK, Schenk S. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine Psychopharmacology. 107: 271-276. PMID 1615126 DOI: 10.1007/BF02245147  0.96
1991 Schenk S, Horger BA, Peltier R, Shelton K. Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Research. 543: 227-35. PMID 1905576 DOI: 10.1016/0006-8993(91)90032-Q  0.96
1991 Peltier R, Schenk S. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats Pharmacology, Biochemistry and Behavior. 39: 133-136. PMID 1833779 DOI: 10.1016/0091-3057(91)90410-4  0.96
1991 Horger BA, Wellman PJ, Morien A, Davies BT, Schenk S. Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport. 2: 53-6. PMID 1768850  0.96
1991 Schenk S, Snow S, Horger BA. Pre-exposure to amphetamine but not nicotine sensitizes rats to the motor activating effect of cocaine Psychopharmacology. 103: 62-66. PMID 1672461 DOI: 10.1007/BF02244075  0.96
1990 Schenk S, Gorman K, Amit Z. Age-dependent effects of isolation housing on the self-administration of ethanol in laboratory rats. Alcohol (Fayetteville, N.Y.). 7: 321-6. PMID 2390208 DOI: 10.1016/0741-8329(90)90090-Y  0.96
1990 Horger BA, Shelton K, Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacology, Biochemistry, and Behavior. 37: 707-11. PMID 2093176 DOI: 10.1016/0091-3057(90)90552-S  0.96
1989 Wellman PJ, Shelton K, Schenk S. Self-administration of phenylpropanolamine (PPA) by rats previously trained to self-administer amphetamine. Pharmacology, Biochemistry, and Behavior. 34: 187-91. PMID 2626448 DOI: 10.1016/0091-3057(89)90371-7  0.96
1988 Schenk S, Robinson B, Amit Z. Housing conditions fail to affect the intravenous self-administration of amphetamine. Pharmacology, Biochemistry, and Behavior. 31: 59-62. PMID 3252261 DOI: 10.1016/0091-3057(88)90311-5  0.96
1988 Schenk S, Robinson B. Differentiation of the substrates for analgesia and vocalizations elicited by midbrain stimulation in rats: Refractory period estimates Behavioural Brain Research. 31: 105-110. PMID 3202942 DOI: 10.1016/0166-4328(88)90012-5  0.96
1987 Schenk S, Lacelle G, Gorman K, Amit Z. Cocaine self-administration in rats influenced by environmental conditions: implications for the etiology of drug abuse. Neuroscience Letters. 81: 227-31. PMID 3696469  0.96
1987 Schenk S, Hunt T, Klukowski G, Amit Z. Isolation housing decreases the effectiveness of morphine in the conditioned taste aversion paradigm. Psychopharmacology. 92: 48-51. PMID 3110828 DOI: 10.1007/BF00215478  0.96
1986 Schenk S, Hunt T, Malovechko R, Robertson A, Klukowski G, Amit Z. Differential effects of isolation housing on the conditioned place preference produced by cocaine and amphetamine. Pharmacology, Biochemistry, and Behavior. 24: 1793-6. PMID 3737645 DOI: 10.1016/0091-3057(86)90523-X  0.96
1985 Schenk S, Prince C, Shizgal P. Spatio-temporal integration in the substrate for self-stimulation of the prefrontal cortex. Physiology & Behavior. 35: 303-6. PMID 4070400 DOI: 10.1016/0031-9384(85)90353-1  0.96
1985 Schenk S, Ellison F, Hunt T, Amit Z. An examination of heroin conditioning in preferred and nonpreferred environments and in differentially housed mature and immature rats. Pharmacology, Biochemistry, and Behavior. 22: 215-20. PMID 3983214 DOI: 10.1016/0091-3057(85)90380-6  0.96
1985 Schenk S, Shizgal P. The substrates for self-stimulation of the lateral hypothalamus and medial prefrontal cortex: a comparison of strength-duration characteristics. Physiology & Behavior. 34: 943-9. PMID 3877312 DOI: 10.1016/0031-9384(85)90017-4  0.96
1985 Schenk S, Nawiesniak E. Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation Pharmacology, Biochemistry and Behavior. 22: 175-177. PMID 2984700 DOI: 10.1016/0091-3057(85)90373-9  0.96
1983 Schenk S, Hunt T, Colle L, Amit Z. Isolation versus grouped housing in rats: differential effects of low doses of heroin in the place preference paradigm. Life Sciences. 32: 1129-34. PMID 6827893 DOI: 10.1016/0024-3205(83)90118-2  0.96
1982 Schenk S, Shizgal P. The substrates for lateral hypothalamic and medial pre-frontal cortex self-stimulation have different refractory periods and show poor spatial summation. Physiology & Behavior. 28: 133-8. PMID 6979054 DOI: 10.1016/0031-9384(82)90114-7  0.96
1982 Schenk S, Britt MD, Atalay J. Isolation rearing decreases opiate receptor binding in rat brain Pharmacology, Biochemistry and Behavior. 16: 841-842. PMID 6283569 DOI: 10.1016/0091-3057(82)90245-3  0.96
1981 Schenk S, Coupal A, Williams T, Shizgal P. A within-subject comparison of the effects of morphine on lateral hypothalamic and central gray self-stimulation. Pharmacology, Biochemistry, and Behavior. 15: 37-41. PMID 7291228 DOI: 10.1016/0091-3057(81)90335-X  0.96
1980 Schenk S, Williams T, Coupal A, Shizgal P. A comparison between the effects of morphine on the rewarding and aversive properties of lateral hypothalamic and central gray stimulation Physiological Psychology. 8: 372-378. DOI: 10.3758/BF03337473  0.96
Show low-probability matches.